Sexual Health Peptides: FDA-Approved & Research Compounds

The sexual health peptide category includes PT-141 (Bremelanotide), marketed as Vyleesi — one of the few FDA-approved peptide drugs outside the GLP-1 class. PT-141 activates melanocortin receptors to treat hypoactive sexual desire disorder in premenopausal women. This category also includes Melanotan II, a research peptide with significant safety concerns that is not approved for human use.

2 compounds in this category